Key result
Oral anticoagulants throughout pregnancy caused no coumarin embryopathy, whereas first-trimester heparin was linked to two cases of life-threatening valve thrombosis.
Why the study?
Does the use of oral anticoagulants throughout pregnancy compared to subcutaneous heparin in the first trimester improve safety and prevent complications in pregnant women with mechanical heart valves?
Cohort (n=63)
Does the use of oral anticoagulants throughout pregnancy compared to subcutaneous heparin in the first trimester improve safety and prevent complications in pregnant women with mechanical heart valves?
Continuous use of oral anticoagulants throughout pregnancy in women with mechanical heart valves may prevent life-threatening valve thrombosis without causing coumarin embryopathy, challenging the routine use of first-trimester heparin.
Answers are grounded in this paper and cite their sources.
May support uninterrupted oral anticoagulation in pregnant mechanical valve patients; leaves open need for randomized confirmation before practice change.
OBJECTIVES: To establish a uniform anticoagulation regimen for pregnant patients with mechanical heart valves taking into account the socio-economic background and to evaluate the incidence of anticoagulant related complications. METHODS: A retrospective study on 63 pregnancies in 21 women with mechanical heart valves was evaluated. These pregnancies were divided into two groups: Group I (n=42) received oral anticoagulants throughout pregnancy and Group II (n=21) received subcutaneous heparin in the 1st trimester and oral anticoagulants for the rest of pregnancy period. Both groups received heparin at time of delivery. RESULTS: There was no case of coumarin embryopathy seen and there was no maternal death. Life threatening valve thrombosis occurred in two patients who were both from Group II and needed emergency re-replacement. Group I had a higher incidence of spontaneous abortion than Group II although this was not statistically significant. CONCLUSIONS: The role of coumarin embryopathy has been overstated. We recommend the use of oral anticoagulants throughout pregnancy especially in countries with similar socio-economic background.
No takes yet. Share an insight, caveat, or question.
Al-Lawati et al. (2002) conducted a cohort in Pregnancy with mechanical heart valves (n=63). Oral anticoagulants throughout pregnancy vs. Subcutaneous heparin in the 1st trimester and oral anticoagulants for the rest of pregnancy was evaluated on Anticoagulant related complications (coumarin embryopathy, maternal death, valve thrombosis, spontaneous abortion). Oral anticoagulants throughout pregnancy caused no coumarin embryopathy, whereas first-trimester heparin was linked to two cases of life-threatening valve thrombosis.
Synapse has enriched 10 related papers. Consider them for comparative context: